David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.89% |
| 2 | Technology | 10.04% |
| 3 | Healthcare | 9.38% |
| 4 | Consumer Discretionary | 8.99% |
| 5 | Industrials | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
V2X
VVX
$2.44B
| $2.31M | ﹤0.01% |
92,853
+28,202
| +44% | +$726K |
|
|
K
2052
CALL
DELISTED
Kellanova
K
| $2.3M | ﹤0.01% |
39,086
| – | – |
|
|
WCIC
2053
DELISTED
WCI Communities, Inc.
WCIC
| $2.3M | ﹤0.01% |
94,345
+68,145
| +260% | +$1.63M |
|
|
SCLN
2054
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $2.3M | ﹤0.01% |
234,062
-22,619
| -9% | -$206K |
|
2055
Titan International
TWI
$455M
| $2.3M | ﹤0.01% |
213,796
-133,753
| -38% | -$1.41M |
|
|
LJPC
2056
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $2.29M | ﹤0.01% |
93,635
-72,479
| -44% | -$1.49M |
|
|
CRR
2057
PUT
DELISTED
Carbo Ceramics Inc.
CRR
| $2.29M | ﹤0.01% |
55,000
-30,700
| -36% | -$1.24M |
|
|
ANN
2058
CALL
DELISTED
ANN INC
ANN
| $2.29M | ﹤0.01% |
47,400
| – | – |
|
|
MERU
2059
DELISTED
MERU NETWORKS INC COM STK (DE)
MERU
| $2.29M | ﹤0.01% |
1,411,502
| – | – |
|
|
INSY
2060
DELISTED
Insys Therapeutics, Inc.
INSY
| $2.29M | ﹤0.01% |
+63,642
| New | +$1.98M |
|
2061
Avery Dennison
AVY
$13.8B
| $2.28M | ﹤0.01% |
37,451
+32,539
| +662% | +$1.89M |
|
2062
Strategic Education
STRA
$1.89B
| $2.28M | ﹤0.01% |
52,945
-40,753
| -43% | -$2M |
|
|
ENIA
2063
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $2.28M | ﹤0.01% |
267,313
-462,117
| -63% | -$4.26M |
|
2064
PUT
Core Laboratories
CLB
$550M
| $2.28M | ﹤0.01% |
20,000
-20,300
| -50% | -$2.46M |
|
2065
DHI Group
DHX
$193M
| $2.28M | ﹤0.01% |
256,598
+12,644
| +5% | +$110K |
|
|
WP
2066
DELISTED
Worldpay, Inc.
WP
| $2.28M | ﹤0.01% |
59,740
+31,152
| +109% | +$1.24M |
|
|
INVX
2067
PUT
Innovex International
INVX
$1.98B
| $2.28M | ﹤0.01% |
30,300
+700
| +2% | +$52.7K |
|
|
RDS.A
2068
PUT
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.28M | ﹤0.01% |
42,190
+10,071
| +31% | +$577K |
|
2069
Tyler Technologies
TYL
$14.4B
| $2.28M | ﹤0.01% |
17,608
+8,177
| +87% | +$1.02M |
|
|
STKL
2070
DELISTED
SunOpta
STKL
| $2.28M | ﹤0.01% |
212,241
-82,173
| -28% | -$868K |
|
|
COL
2071
PUT
DELISTED
Rockwell Collins
COL
| $2.27M | ﹤0.01% |
+24,600
| New | +$2.37M |
|
|
TSS
2072
DELISTED
Total System Services, Inc.
TSS
| $2.27M | ﹤0.01% |
54,398
+6,326
| +13% | +$256K |
|
2073
Hercules Capital
HTGC
$3.3B
| $2.27M | ﹤0.01% |
+196,645
| New | +$2.55M |
|
2074
PUT
KB Home
KBH
$3.44B
| $2.27M | ﹤0.01% |
+136,600
| New | +$2.08M |
|
2075
PUT
Ionis Pharmaceuticals
IONS
$10.5B
| $2.27M | ﹤0.01% |
39,400
+10,200
| +35% | +$649K |
|
Similar funds
David Shaw's Q2 2015 Portfolio in Review
As of Q2 2015, David Shaw held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw's Q2 2015 filing shows 504 new, 1,541 increased, 1,229 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Technology and Healthcare.
- David Shaw's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- David Shaw added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- David Shaw's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- David Shaw fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- David Shaw's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- David Shaw opened 504 new positions and closed 364 in Q2 2015.
- David Shaw's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.